Government Briefs

A Stealth Technology Policy? Critics of the Bush administration's approach to what is nowadays called technology policy - that is, government actions meant to strengthen certain industries deemed essential for the health of the U.S. economy - had a field day during a hearing last month on the subject before the Senate Commerce, Science, and Transportation Committee. The chairman, Sen. Ernest Hollings (D-S.C.), wondered whether a range of such key technologies "will receive government backing or


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A Stealth Technology Policy? Critics of the Bush administration's approach to what is nowadays called technology policy - that is, government actions meant to strengthen certain industries deemed essential for the health of the U.S. economy - had a field day during a hearing last month on the subject before the Senate Commerce, Science, and Transportation Committee. The chairman, Sen. Ernest Hollings (D-S.C.), wondered whether a range of such key technologies "will receive government backing or government indifference." Griffith Resor, president of MRS Technology Inc., a Massachusetts company that makes multimillion-dollar tools for the high-resolution photolithography industry, cracked that "the president's technology policy must be classified because it's one of the best-kept secrets in Washington." In turn, presidential science adviser Allan Bromley defended the administration's actions by saying that the country faces "deep, structural problems" that have to do more with the high cost of capital, the emphasis on short-term ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio